HDT bio's Rapid-Response Roadmap for RNA vaccines (R4) project granted a five-year subaward for $2M per year SEATTLE, Sept. 17, 2024 /PRNewswire/ -- HDT Bio Corp., a clinical-stage ...

In the twentieth century, the development and delivery of vaccines as part of large, systematic immunization programs helped to address many health inequities. However, safety concerns due to ...

Two key players looking to help Kiwi farmers reduce their emissions have given a new company some additional funding to craft a methane vaccine ... to Lucidome Bio to fund their research.

Here's what to know about the latest vaccines, who needs them and how they help prevent the more serious effects of COVID-19. The FDA granted emergency use authorization last week to an updated ...

New Delhi: The Central Drugs Standard Control Organization (CDSCO) has published a list of the details of manufacturers whose ...

Last year was the first year that the US had vaccines available to protect against all three major respiratory viruses — Covid-19, flu and RSV — but vaccine uptake was low for the season.

Aug 30 (Reuters) - The U.S. Food and Drug Administration granted expanded approval to Emergent BioSolutions' (EBS.N), opens new tab smallpox vaccine for use in people at high risk of mpox infection.

MinervaX, a privately-held Danish biotechnology company developing a vaccine against Group B Streptococcus (GBS), and Wacker Biotech, a CDMO, agreed to collaborate on the manufacture of MinervaX ...

The Centers for Disease Control and Prevention (CDC) has published a warning (Inadvertent intradermal administration of tetanus toxoid-containing vaccines instead of tuberculosis skin tests ...

(Reuters) -The U.S. Food and Drug Administration granted expanded approval to Emergent BioSolutions' smallpox vaccine for use in people at high risk of mpox infection. The FDA clearance ...